|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.718
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.700
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.694
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.536
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.517
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.477
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.463
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.364
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.354
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.313
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.300
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.281
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.246
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.244
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.203
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.202
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.200
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.187
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.183
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.181
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.175
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.170
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.164
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.162
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.149
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.145
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.142
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.136
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.135
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.134
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.130
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.125
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.122
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.120
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.118
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.116
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.113
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.111
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.110
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.107
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.105
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.104
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.103
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.103
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.103
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.102
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.100
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.098
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.098
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.097
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.096
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.096
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.096
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.095
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.095
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.094
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.093
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.093
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.092
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.092
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.092
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.089
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.089
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.089
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.088
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.088
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.087
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.087
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.087
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.086
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.084
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.084
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.083
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.083
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.083
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.083
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.083
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.082
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.081
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.081
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.081
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.081
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.081
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.080
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.080
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.080
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.080
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.080
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.079
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.079
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.079
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.078
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.078
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.078
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.078
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.078
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.078
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.077
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.077
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.076
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.076
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.076
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.076
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.076
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.073
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.073
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.072
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.072
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.072
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.072
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.071
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.071
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.071
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.070
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.069
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.069
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.069
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.068
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.068
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.068
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.067
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.067
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.067
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.066
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.066
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.066
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.066
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.066
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.066
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.066
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.065
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.065
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.065
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.065
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.065
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.064
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.064
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.064
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.064
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.064
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.063
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.063
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.062
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.061
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.061
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.061
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.060
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.060
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.060
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.060
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.059
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.059
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.059
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.059
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.059
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.059
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.058
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.058
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.058
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.058
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.058
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.058
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.057
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.057
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.057
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.057
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.057
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.057
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.057
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.057
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.056
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.056
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.056
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.055
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.055
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.055
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.054
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.054
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.054
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.054
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.054
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.053
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.053
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.053
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.053
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.052
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.052
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.052
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.051
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.051
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.051
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.051
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.051
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.050
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.050
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.049
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.049
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.049
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.049
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.049
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.048
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.048
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.048
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.048
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.048
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.048
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.047
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.047
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.046
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.046
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.046
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.046
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.046
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.045
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.045
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.045
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.044
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.044
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.044
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.044
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.044
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.043
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.043
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.043
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.043
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.043
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.043
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.043
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.042
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.042
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.042
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.042
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.042
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.042
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.042
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.042
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.041
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.041
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.041
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.041
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.041
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.041
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.041
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.041
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.041
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.041
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.040
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.040
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.040
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.040
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.040
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.040
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.040
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.040
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.039
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.039
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.039
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.039
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.039
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.039
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.038
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.038
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.038
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.038
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.038
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.038
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.037
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.037
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.037
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.037
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.037
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.036
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.036
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.036
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.036
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.035
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.035
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.035
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.035
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.035
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.035
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.035
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.035
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.035
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.035
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.035
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.035
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.035
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.035
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.035
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.034
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.034
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.034
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.034
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.034
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.034
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.034
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.034
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.034
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.034
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.033
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.033
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.033
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.033
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.033
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.033
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.033
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.033
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.033
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.032
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.032
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.032
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.032
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.032
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.032
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.032
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.032
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.032
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.032
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.032
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.032
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.032
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.032
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.032
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.032
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.032
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.032
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.032
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.031
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.031
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.031
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.031
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.031
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.031
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.031
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.031
|
|
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.031
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.031
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.031
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.031
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.031
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.031
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.031
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.031
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.030
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.030
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.030
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.030
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.030
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.030
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.030
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.029
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.029
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.029
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.029
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.029
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.029
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.029
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.029
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.029
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.029
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.029
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.029
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.029
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.029
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.029
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.029
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.029
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.029
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.029
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.028
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.028
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.028
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.028
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.028
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.028
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.028
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.028
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.028
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.028
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.028
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.028
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.028
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.028
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.027
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.027
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.027
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.027
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.027
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.027
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.027
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.027
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.027
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.027
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.027
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.027
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.027
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.027
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.027
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.027
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.026
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.026
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.026
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.026
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.026
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.026
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.026
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.026
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.026
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.026
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.026
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.026
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.026
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.026
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.026
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.026
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.025
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.025
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.025
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.025
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.025
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.025
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.025
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.025
|
|
|
|
metanephric renal vesicle morphogenesis
|
GO:0072283 |
12 |
0.025
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.025
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.025
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.025
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.025
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.025
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.025
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.024
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.024
|
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.024
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.024
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.024
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.024
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.024
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.024
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.024
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.024
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.024
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.024
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.024
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.024
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.024
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.024
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.024
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.024
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.024
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.024
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.024
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.024
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.023
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.023
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.023
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.023
|
|
|
|
regulation of cell growth involved in cardiac muscle cell development
|
GO:0061050 |
3 |
0.023
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.023
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.023
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.023
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.023
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.023
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.023
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.023
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.023
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.023
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.023
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.023
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.023
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.023
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.023
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.022
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.022
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.022
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.022
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.022
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.022
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.022
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.022
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.022
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.022
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.022
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.022
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.022
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.022
|
|
